Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
Likes Subject
Older
Anybody have any theories here? What’s really going on? OTC_Hussler 01/04/23 10:30 AM
Would love to see $10.00! OTC_Hussler 11/10/22 9:32 PM
Slow accumulation been happening the past few months. Lowhndcpr 11/10/22 9:03 AM
ImmunoCellular Therapeutics Ltd. changed to EOM Pharmaceutical Holdings Renee 11/08/22 5:13 PM
How long has VNDM been in the ask? OTC_Hussler 10/07/22 3:48 PM
The valuation is what will change. And most biotechs Benwahsauce 09/22/22 9:14 AM
Possibly. But its going to depend on where OTC_Hussler 09/22/22 9:12 AM
$5.00 still too low. Benwahsauce 09/22/22 8:53 AM
Im looking for $5.00 here sooner than later. OTC_Hussler 09/22/22 5:25 AM
$1 is much too low. This stock could Benwahsauce 09/21/22 4:45 PM
Nice buys today. Hoping to be over a Lowhndcpr 09/21/22 2:48 PM
Raised $750k with convertible note. https://www.sec.gov/Archives/edgar/data/8224 OTC_Hussler 09/12/22 4:41 PM
We’re going to laugh all the way to OTC_Hussler 08/01/22 11:46 AM
Nice to see myself in the green here Lowhndcpr 07/29/22 4:01 PM
Confirmed yet? OTC_Hussler 07/28/22 6:52 PM
We shall discuss later when confirmed. There can be Benwahsauce 07/22/22 11:37 PM
Something derogatory or Continuous Net Settlement. OTC_Hussler 07/21/22 9:13 PM
The real question is….what do you think it means??? Benwahsauce 07/21/22 4:41 PM
Educate me on the meaning of CNS and OTC_Hussler 07/21/22 2:40 PM
Finally all CNS funneled out! Go time is near Benwahsauce 07/21/22 12:44 PM
funnel out the CNS's Golf4Food 07/21/22 11:33 AM
Yes Sir! I's waiting! OTC_Hussler 07/11/22 10:45 AM
I find it funny that last 6 months Benwahsauce 07/07/22 1:04 PM
No shares below. This is really good Benwahsauce 07/05/22 10:46 AM
Are they stop loss hunting today? OTC_Hussler 06/30/22 3:28 PM
You never know! Benwahsauce 06/30/22 10:04 AM
I'm hoping so! OTC_Hussler 06/30/22 9:14 AM
Promise there’s a good chance it flies even Benwahsauce 06/30/22 8:46 AM
Im thinking $2 to $3.50 coming next 90 days. OTC_Hussler 06/29/22 10:31 PM
S-1 filing. This is great news. To be Benwahsauce 06/29/22 11:43 AM
Form S-1 Filled today. OTC_Hussler 06/24/22 4:31 PM
But you can get than many at one OTC_Hussler 06/17/22 1:38 PM
Lol why would I do that when people Benwahsauce 06/15/22 9:03 PM
I’ll take $300k for 142,752 shares today. OTC_Hussler 06/15/22 9:50 AM
Again I’m not complaining, if you want Benwahsauce 06/15/22 9:41 AM
Infact my bid will not fill and it Benwahsauce 06/15/22 9:40 AM
Who knows? They have slipped the share price OTC_Hussler 06/15/22 9:40 AM
How can they sell shares with little volume? Benwahsauce 06/15/22 9:37 AM
Because it takes money to run a business. OTC_Hussler 06/15/22 9:15 AM
Why bring in money when they can load Benwahsauce 06/15/22 9:04 AM
Of they have positive results they would need OTC_Hussler 06/15/22 9:04 AM
Or are they? OTC reporting is not like it Benwahsauce 06/15/22 8:59 AM
I’ve been here since 2017. Not selling now OTC_Hussler 06/15/22 8:52 AM
When they are ready. I’m sitting bid. Benwahsauce 06/15/22 8:15 AM
When’s something going to drop? They are 7 OTC_Hussler 06/14/22 9:31 PM
Lol nobody sees this buying going on? This is Benwahsauce 05/20/22 5:55 PM
That’s awesome news! Glad they are legit! OTC_Hussler 05/13/22 9:12 AM
Best part is the company is legitimate as Benwahsauce 05/12/22 11:58 PM
Last shake be for they have to release OTC_Hussler 05/12/22 8:21 PM
Lmfao I’m surprised they are continuing this. Benwahsauce 05/12/22 3:18 PM
Likes Subject
Older

Older
OTC_Hussler
01/04/23 10:30 AM
OTC_Hussler
11/10/22 9:32 PM
Lowhndcpr
11/10/22 9:03 AM
Renee
11/08/22 5:13 PM
OTC_Hussler
10/07/22 3:48 PM
Benwahsauce
09/22/22 9:14 AM
OTC_Hussler
09/22/22 9:12 AM
Benwahsauce
09/22/22 8:53 AM
OTC_Hussler
09/22/22 5:25 AM
Benwahsauce
09/21/22 4:45 PM
Lowhndcpr
09/21/22 2:48 PM
OTC_Hussler
09/12/22 4:41 PM
OTC_Hussler
08/01/22 11:46 AM
Lowhndcpr
07/29/22 4:01 PM
OTC_Hussler
07/28/22 6:52 PM
Benwahsauce
07/22/22 11:37 PM
OTC_Hussler
07/21/22 9:13 PM
Benwahsauce
07/21/22 4:41 PM
OTC_Hussler
07/21/22 2:40 PM
Benwahsauce
07/21/22 12:44 PM
Golf4Food
07/21/22 11:33 AM
OTC_Hussler
07/11/22 10:45 AM
Benwahsauce
07/07/22 1:04 PM
Benwahsauce
07/05/22 10:46 AM
OTC_Hussler
06/30/22 3:28 PM
Benwahsauce
06/30/22 10:04 AM
OTC_Hussler
06/30/22 9:14 AM
Benwahsauce
06/30/22 8:46 AM
OTC_Hussler
06/29/22 10:31 PM
Benwahsauce
06/29/22 11:43 AM
OTC_Hussler
06/24/22 4:31 PM
OTC_Hussler
06/17/22 1:38 PM
Benwahsauce
06/15/22 9:03 PM
OTC_Hussler
06/15/22 9:50 AM
Benwahsauce
06/15/22 9:41 AM
Benwahsauce
06/15/22 9:40 AM
OTC_Hussler
06/15/22 9:40 AM
Benwahsauce
06/15/22 9:37 AM
OTC_Hussler
06/15/22 9:15 AM
Benwahsauce
06/15/22 9:04 AM
OTC_Hussler
06/15/22 9:04 AM
Benwahsauce
06/15/22 8:59 AM
OTC_Hussler
06/15/22 8:52 AM
Benwahsauce
06/15/22 8:15 AM
OTC_Hussler
06/14/22 9:31 PM
Benwahsauce
05/20/22 5:55 PM
OTC_Hussler
05/13/22 9:12 AM
Benwahsauce
05/12/22 11:58 PM
OTC_Hussler
05/12/22 8:21 PM
Benwahsauce
05/12/22 3:18 PM

EOM Pharmaceutical Holdings Inc. (IMUC)

Followers
180
Posters
565
Posts (Today)
0
Posts (Total)
5845
Created
10/10/08
Type
Free
Moderators

https://www.imuc.com/
About IMMUNOCELLULAR THERAPEUTICS LTD
ImmunoCellular Therapeutics, Ltd. is a clinical-stage company, which
 engages in the development of immune-based therapies for the treatment
 of cancers. The company's lead product candidate, ICT-107, is a 
dendritic cell-based immunotherapy targeting multiple tumor-associated
 antigens on glioblastoma stem cells. Its pipeline also includes ICT-
121, a patient-specific, dendritic cell-based immunotherapy targeting
 the CD133 antigen on stem cells in recurrent glioblastoma; ICT-140, a
 patient-specific, dendritic cell-based immunotherapy targeting antigens
 on ovarian cancer stem cells; and the Stem-to-T-cell research program
 which engineers the patient's hematopoietic stem cells to generate
 antigen-specific cancer-killing T cells. The company was founded on
 January 30, 2006 and is headquartered in Los Angeles, CA.

Contacts:

For EOM Pharmaceuticals, Inc:
INVESTOR CONTACT: Wayne I. Danson
Chief Financial Officer & Treasurer
EOM Pharmaceuticals, Inc.
wayned@eompharma.com  
516.384.9757

MEDIA CONTACT: Taylor Mason-Little
TogoRun
t.mason-little@togorun.com
714.466.0301

For ImmunoCellular Therapeutics, Inc:
Jane M. Green
jane@jmgcomm.com
267.457.3734 office
415.652.4819 mobile

SOURCE EOM Pharmaceuticals, Inc.

IMUC SHARE STRUCTURE
  Authorized Shares: 500,000,000 12/31/2021
                                  50,000,000 12/31/2020
Outstanding Shares:   113,270,751  01/05/2022
                                49,270,751 12/03/2021
                                     4,195,213  12/31/2020
          Held at DTC:    4,192,547 12/03/2021
https://www.otcmarkets.com/stock/IMUC/security
Links to see recent MM short volume sales & short interest activity
https://iborrowdesk.com/report/IMUC 15min update
https://marketwirenews.com/stock/imuc/short/ trading + cover days + charts
https://whalewisdom.com/stock/imuc#short_positions 30min updated
http://shortvolumes.com/?t=imuc daily intraday
https://fintel.io/ss/us/imuc bi-monthly + daily intraday
https://shortsqueeze.com/?symbol=imuc&submit=Short+Quote%E2%84%A2 bi-monthly
https://otce.finra.org/otce/equityShortInterest bi-monthly

Recent News
Proposed Reverse Merger EOM & IMUC December 2, 2021
https://www.otcmarkets.com/stock/IMUC/news/EOM-Pharmaceuticals-Inc-And-Immunocellular-Therapeutics-Ltd-Announce-Entry-Into-And-Close-Of-Definitive-Merger-Agreement?id=333764


https://www.eompharma.com/

About EOM Pharmaceuticals
EOM Pharmaceuticals is a clinical-stage company focused on developing
 drugs with the potential to transform therapeutic paradigms and improve
 quality of life in patients suffering from debilitating and sometimes
 deadly diseases, including infectious diseases such as COVID-19; autoimmune
 diseases including rheumatoid arthritis; cachexia associated with AIDS
 and cancer; and retinal diseases. For more information about EOM
 Pharmaceuticals, please visit www.eompharma.com.

weekly

8-34 Daily 180d

Daily 90d
Most Liked Posts
(Last 30 Days)
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Detailed Quote
IMUC Latest News
More IMUC News
Most Liked Posts
(Last 30 Days)
New Post